Ignite Creation Date:
2025-12-24 @ 12:01 PM
Ignite Modification Date:
2026-02-25 @ 6:57 PM
Study NCT ID:
NCT02059161
Status:
COMPLETED
Last Update Posted:
2018-09-05
First Post:
2014-02-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-17
Start Date Type:
ACTUAL
Primary Completion Date:
2015-05-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-11-12
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-07
First Submit QC Date:
None
Study First Post Date:
2014-02-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-17
Results First Submit QC Date:
None
Results First Post Date:
2017-03-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-07
Last Update Post Date:
2018-09-05
Last Update Post Date Type:
ACTUAL